Shareholder Information

Shares Issued

As at 28 June 2021, the number of shares in issue was 25,871,612. The company does not hold any ordinary shares in treasury.

Significant Shareholders

At 23 June 2021, the Company has been notified of the following interests in 3% or more of the issued ordinary share capital of the Company:

Shareholder	No. of ordinary shares	% of issued share capital
Invest Northern Ireland	3,197,865	12.39
Amati Global Investors Limited	2,341,463	9.07
Viridian Growth Fund LP	1,831,500	7.09
Octopus Investments Limited	1,525,258	5.91
Hargreave Hale Limited	1,402,439	5.43
Jim Johnston	1,317,325	5.10
Canaccord Genuity	1,268,865	4.91
Livingbridge VC LLP	1,219,512	4.72
Unicorn AIM VCT plc	1,219,512	4.72
Paul Warwick	1,036,363	4.01

Director Shareholdings

Director	No. of ordinary shares	% of issued share capital
Dr Richard John Buick	611,250	2.37
Dr Simon Gordon Douglas	255,800	0.99
Dr Alan Mawson ¹	124,000	0.48
Sonya Maria Ferguson	67,567	0.26
Timothy William Watts	27,575	0.11
Colin James Walsh ²	-	-
James Alexander Fair	-	-

(1) Alan Mawson is a non-executive director of Clarendon Fund Managers Limited ("Clarendon") and sits on Clarendon's investment committee. Clarendon is the fund manager for Nitech Growth Fund LP which holds 358,850 Ordinary Shares and Viridian Growth Fund LP which holds 1,831,500 Ordinary Shares.
(2) Colin Walsh is the Chief Executive and founder of Crescent Capital NI Limited, which is the fund manager for Crescent Capital II LP and Crescent Capital III LP which hold 2,652,325 Ordinary Shares and 731,707 Ordinary Shares respectively.